Providence Medical Technology receives $10.5M new equity financing — 5 points

Spinal Tech

Walnut Creek, Calif.-based Providence Medical Technology closed a new equity financing round of $10.5 million.

Here are five points:

 

1. The company plans to use the funding to boost the commercialization of its cervical fusion technology portfolio.

 

2. London, U.K.-based MVM Life Science Partners, a new investor, led the financing. The company is now a part of Providence's board of directors.

 

3. Jupiter, Fla.-based Stanmore Medical Investments and Mill Valley, Calif.-based Aphelion Capital also participated in the financing round.

 

4. Providence develops tissue-sparing, cervical fusion technology.  

 

5. The company is currently working on commercializing the DTRAX platform of single-use, tissue-sparing instruments and CAVUX implants for cervical fusion.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers